Comparison of Humira biosimilars in the US and Europe
Pharmaceutical Technology
MARCH 24, 2023
However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016. Further, there remains scepticism on the efficacy and safety of biosimilars. Sometimes the settlement of a patent dispute involves agreeing to defer entry.
Let's personalize your content